Trial Profile
Efficacy of Oral Alitretinoin Versus Oral Azathioprine in Patients With Severe Chronic Non-hyperkeratotic Hand Eczema. A Randomized Prospective Open-label Trial With Blinded Outcome Assessment
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Alitretinoin (Primary) ; Azathioprine (Primary)
- Indications Eczema
- Focus Therapeutic Use
- 01 May 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 01 May 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.
- 01 Feb 2017 New trial record